MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival

Oncogene

Volumn 34, Issue 20, 2015, Pages 2556-2565

  Li, B S ^a   Zuo, Q F ^a   Zhao, Y L ^a   Xiao, B ^a   Zhuang, Y ^a   Mao, X H ^a   Wu, C ^a   Yang, S M ^a   Zeng, H ^a   Zou, Q M ^a   Guo, G ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN25 MICRORNA, HUMAN; RNA; SIGNAL PEPTIDE; TOB1 PROTEIN, HUMAN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; MOUSE; NUDE MOUSE; PATHOLOGY; STOMACH TUMOR; SURVIVAL RATE; TUMOR INVASION;

ADULT; AGED; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA, NEOPLASM; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84938053005     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.214     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clinicians 2011; 61: 69-90.
2. Ushijima T, Sasako M. Focus on gastric cancer. Cancer cell 2004; 5: 121-125.
3. Zhang C. Novel functions for small RNA molecules. Curr Opin Mol Ther 2009; 11: 641-651.
4. Lujambio A, Lowe SW. The microcosmos of cancer. Nature 2012; 482: 347-355.
5. Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012; 492: 376-381.
6. Swarbrick A, Woods SL, Shaw A, Balakrishnan A, Phua Y, Nguyen A et al. miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nat Med 2010; 16: 1134-1140.
7. Zhao X, Dou W, He L, Liang S, Tie J, Liu C et al. MicroRNA-7 functions as an antimetastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 2013; 32: 1363-1372.
8. Yao Q, Cao Z, Tu C, Zhao Y, Liu H, Zhang S. MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer Lett 2013; 335: 219-224.
9. Zheng B, Liang L, Huang S, Zha R, Liu L, Jia D et al. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene 2012; 31: 4509-4516.
10. Gao P, Xing AY, Zhou GY, Zhang TG, Zhang JP, Gao C et al. The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene 2013; 32: 491-501.
11. Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y et al. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol 2012; 19(Suppl 3): S656-S664.
12. Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X et al. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS ONE 2012; 7: E41629.
13. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y et al. The miR-106b-25 Polycistron, Activated by Genomic Amplification, Functions as an Oncogene by Suppressing p21 and Bim. Gastroenterology 2009; 136: 1689-1700.
14. Xu X, Chen Z, Zhao X, Wang J, Ding D, Wang Z et al. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem Biophys Res Commun 2012; 421: 640-645.
15. Kim BH, Hong SW, Kim A, Choi SH, Yoon SO. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surj Oncol 2013; 107: 505-510.
16. Akagi T, Kimoto T. Human cell line (HGC-27) derived from the metastatic lymph node of gastric cancer. Acta medica Okayama 1976; 30: 215-219.
17. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, De Martino I et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer cell 2008; 13: 272-286.
18. Yu J, Liu P, Cui X, Sui Y, Ji G, Guan R et al. Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions. Mol Cells 2011; 32: 47-55.
19. Kundu J, Wahab SM, Kundu JK, Choi YL, Erkin OC, Lee HS et al. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting betacatenin signaling. Int J Oncol 2012; 41: 839-848.
20. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH et al. Functional links between clustered microRNAs: Suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009; 37: 1672-1681.
21. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-689.
22. Wang X, Guo B, Li Q, Peng J, Yang Z, Wang A et al. miR-214 targets ATF4 to inhibit bone formation. Nat Med 2013; 19: 93-100.
23. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B et al. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 2010; 107: 264-269.
24. Wahlquist C, Jeong D, Rojas-Munoz A, Kho C, Lee A, Mitsuyama S et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 2014; 508: 531-535.
25. Razumilava N, Bronk SF, Smoot RL, Fingas CD, Werneburg NW, Roberts LR et al. miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology 2012; 55: 465-475.
26. Brett JO, Renault VM, Rafalski VA, Webb AE, Brunet A. The microRNA cluster miR-106b ~ 25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation. Aging 2011; 3: 108-124.
27. Li Q, Zou C, Zou C, Han Z, Xiao H, Wei H et al. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett 2013; 335: 168-174.
28. Esposito F, Tornincasa M, Pallante P, Federico A, Borbone E, Pierantoni GM et al. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J Clin Endocrinol Metab 2012; 97: E710-E718.
29. Zhao H, Wang Y, Yang L, Jiang R, Li W. miR-25 promotes gastric cancer cells growth and motility by targeting RECK. Mol Cell Biochem 2013; 385: 207-213.
30. Jiao Y, Sun KK, Zhao L, Xu JY, Wang LL, Fan SJ. Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1). Acta Pharmacol Sin 2012; 33: 250-260.
31. Matsuda S, Kawamura-Tsuzuku J, Ohsugi M, Yoshida M, Emi M, Nakamura Y et al. Tob, a novel protein that interacts with p185erbB2, is associated with antiproliferative activity. Oncogene 1996; 12: 705-713.
32. Iwanaga K, Sueoka N, Sato A, Sakuragi T, Sakao Y, Tominaga M et al. Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer. Cancer Lett 2003; 202: 71-79.
33. Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N et al. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 2000; 103: 1085-1097.
34. Yoshida Y, von Bubnoff A, Ikematsu N, Blitz IL, Tsuzuku JK, Yoshida EH et al. Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling. Mech Dev 2003; 120: 629-637.
35. Xiong B, Rui Y, Zhang M, Shi K, Jia S, Tian T et al. Tob1 controls dorsal development of zebrafish embryos by antagonizing maternal beta-catenin transcriptional activity. Dev Cell 2006; 11: 225-238.
36. Ezzeddine N, Chang TC, Zhu W, Yamashita A, Chen CY, Zhong Z et al. Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation. Mol Cell Biol 2007; 27: 7791-7801.
37. Helms MW, Kemming D, Contag CH, Pospisil H, Bartkowiak K, Wang A et al. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer. Cancer Res2009; 69: 5049-5056.
38. Scapoli L, Palmieri A, Lo Muzio L, Pezzetti F, Rubini C, Girardi A et al. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 2010; 23: 1229-1234.
39. Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sanudo A, Camara-Lopes LH et al. MicroRNA expression profiles in the progression of prostate can cer-from high-grade prostate intraepithelial neoplasia to metastasis. Urol Oncol 2013; 31: 796-801.